Stephens & Co. Maintains Overweight on Addus HomeCare, Lowers Price Target to $105
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel maintains an Overweight rating on Addus HomeCare (NASDAQ:ADUS) but lowers the price target from $110 to $105.
November 01, 2023 | 2:05 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Despite the lowered price target, Stephens & Co. maintains an Overweight rating on Addus HomeCare, indicating a positive outlook.
The news directly pertains to Addus HomeCare (ADUS). Despite the lowered price target, the maintained Overweight rating indicates that the analyst still has a positive outlook on the company. This could potentially neutralize the impact of the lowered price target in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100